Senior insider sale
EVP & Chief Financial Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$387.4K
39.35K shares
What this filing means
O'BYRNE JASON plans to sell 39.35K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $387.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/24/2026ACC: 0001959173-26-006413
Officer· EVP & Chief Financial Officer
Since Feb 2026
39.35K
Shares to sell
$387.4K
Approx. market value
14.35K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/24/2026
14.35KTotal acquired14.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/24/2026 | Stock Option Exercise Cash | 14.35K | — |
| Total | 14.35K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
25K
Market value
$245.3K
8/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.35K
Market value
$142.1K
8/24/2026
Total
Units
39.35K
Value
$387.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/21/2026 | 25K | $245.3K | — | Completed |
| Planned — Approximate Date | ||||
8/24/2026 | 14.35K | $142.1K | NASDAQ | Planned |
| Total | 39.35K | $387.4K | ||